<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Cross Timbers Royalty Trust</title>
	<atom:link href="http://www.stockbloghub.com/tag/cross-timbers-royalty-trust/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MDT) Medtronic Reports Enrollment in its Attain Success Trial</title>
		<link>http://www.stockbloghub.com/2009/11/14/mdt-medtronic-reports-enrollment-in-its-attain-success-trial/20457</link>
		<comments>http://www.stockbloghub.com/2009/11/14/mdt-medtronic-reports-enrollment-in-its-attain-success-trial/20457#comments</comments>
		<pubDate>Sat, 14 Nov 2009 22:55:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[Cross Timbers Royalty Trust]]></category>
		<category><![CDATA[CRT]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20457</guid>
		<description><![CDATA[Medtronic Inc. (MDT) recently reported the first enrollment for its Attain Success trial. The trial evaluates implant success, complication rates and procedure times for the company’s Attain Family of left-heart leads and delivery systems portfolio which are already available in the market. The Attain Success trial enrollment will have roughly 2,000 patients at 150 medical centers in 18 countries around the world. The company will analyze data at baseline, implant and three months post-implant. The study will also capture implant success and complication rates (up to three months), procedure times, handling feedback and physician survey data. In addition, the Attain Success trial enrollment will have a sub-study that will assess final left-heart lead placement site. Patients enrolled in the test will have a cardiac resynchronization therapy-defibrillator (CRT) device implanted in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/14/mdt-medtronic-reports-enrollment-in-its-attain-success-trial/20457/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

